Patent details

EP2661493 Title: PLASMINOGEN AND PLASMIN VARIANTS

Basic Information

Publication number:
EP2661493
PCT Application Number:
PCT/EP/2012/050074
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127001543
PCT Publication Number:
WO/2012/093132
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PLASMINOGEN AND PLASMIN VARIANTS
French Title of Invention:
VARIANTES DE PLASMINOGÈNE ET DE PLASMINE
German Title of Invention:
PLASMINOGEN- UND PLASMINVARIANTEN
SPC Number:

Dates

Filing date:
04/01/2012
Grant date:
30/03/2016
EP Publication Date:
30/03/2016
PCT Publication Date:
12/07/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/11/2013
EP B1 Publication Date:
30/03/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
04/01/2017
Expiration date:
04/01/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/01/2012
 
 

Name:
ThromboGenics N.V.
Address:
Gaston Geenslaan 1, 3001 Heverlee, Belgium (BE)

Inventor

Name:
ZWAAL Richard Reinier
Address:
Belgium (BE)

Priority

1

Priority Number:
201161429868
Priority Date:
05/01/2011
Priority Country:
United States (US)

2

Priority Number:
11150246
Priority Date:
05/01/2011
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 45/06;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages